Solitary Pulmonary Nodule Clinical Trial
Official title:
Prospective Multi-center Study Using a Bronchoscopic Ultrasound-Guided Needle Biopsy System With Real-time Visualization in Endobronchial Lesions, Peripheral Lung Nodules, or Lung Masses
NCT number | NCT05804435 |
Other study ID # | E7186 |
Secondary ID | |
Status | Withdrawn |
Phase | N/A |
First received | |
Last updated | |
Start date | January 2025 |
Est. completion date | February 2027 |
Verified date | March 2024 |
Source | Boston Scientific Corporation |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to collect information on the iNod™ System's safety and ability to see the iNod™ biopsy needle in real-time in endobronchial lesions, peripheral lung nodules, or lung masses.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | February 2027 |
Est. primary completion date | February 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Age 18 years or older. 2. Subject willing and able to comply with study procedures and provide written informed consent to participate in study. 3. Subject with a predominantly solid, peripheral lung lesion, 1 cm to 5 cm in diameter measured along its longest cross sectional diameter on axial CT imaging (obtained within 4 weeks per standard of practice) with the intention to undergo a clinically indicated bronchoscopic evaluation under routine clinical care. If the lesion is partially solid (i.e. there is a ground glass component) then the solid portion must make up at least 80% of the lesion. a. "Peripheral" lesion in this study will be pragmatically defined as any lesion in the lung parenchyma that the clinician feels cannot be accessed successfully using the convex probe endobronchial ultrasound bronchoscope. 4. Subject for whom the decision to pursue biopsy has been made by the treating physician and agreed upon by the subject. Exclusion Criteria: 1. Subjects with pure ground glass opacity or a subsolid target lesion, and/or a ground glass opacity for which less than 80% of the lesion is solid identified by Chest CT. 2. Subjects who have medical contraindication to undergo conventional flexible or robotic bronchoscopy and standard of care Radial EBUS-guided cytological assessment evaluations, as determined by the investigator. 3. Subjects with known coagulopathy. 4. Subjects who are pregnant or nursing mothers. 5. Subjects who are currently enrolled in another investigational study that would directly interfere with the current study, without prior written approval from the sponsor. 6. Use of intraprocedural Cone Beam CT, Fixed CT or Augmented fluoroscopy |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Boston Scientific Corporation |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Biopsy Yield | Diagnostic biopsy yield, defined as ability for histopathologist to report a specific benign or malignant diagnosis, stratified by concentric and eccentric lesion location. | Procedure | |
Other | Diagnostic Accuracy | Diagnostic accuracy at 12 months. | 12 months post procedure | |
Other | Device Rotation | Ability to reposition the needle into a different location within targeted lesions, if desired. | Procedure | |
Other | Crossover Rate | Crossover rate to radial EBUS or any alternative standard of care procedure. | Procedure | |
Primary | Proportion of patients where the needle is visualized by the iNOD system inside the lesion | Successful "Tool in lesion", defined as visualization of the tracheobronchial biopsy needle (TBNA) inside the targeted lesion within the ultrasound field of view. | Procedure | |
Primary | Adverse Events | Proportion of subjects with Adverse Events related to the iNod device and/or study procedure, as well as Adverse Events related to any subsequent crossover procedures. | Procedure |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05066776 -
Liquid Biopsy With PET/CT Versus PET/CT Alone in Diagnosis of Small Lung Nodules
|
||
Completed |
NCT01958931 -
Evaluate the Utility of the ProLung Test as Adjunctive to CT Scan in the Diagnosis of Lung Cancer
|
N/A | |
Recruiting |
NCT03528733 -
Feasibility of Multi-Energy Digital Radiography Detector for Lung Lesions Detection
|
N/A | |
Recruiting |
NCT02693496 -
Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
|
||
Completed |
NCT01566682 -
A Multi-Center Trial of the ProLung Test™
|
||
Terminated |
NCT02983903 -
Cryobiopsy Versus Forceps Biopsy for Pulmonary Lesions
|
N/A | |
Terminated |
NCT02050724 -
ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT
|
Phase 2 | |
Not yet recruiting |
NCT04615156 -
18F-2-fluoro-2-deoxy-D-glucose in Positron Emission Tomography Computed Tomography
|
Phase 3 | |
Recruiting |
NCT02726633 -
Evaluate the Utility of the ProLung China Test in the Diagnosis of Lung Cancer
|
N/A | |
Active, not recruiting |
NCT02623712 -
The Watch the Spot Trial
|
N/A | |
Recruiting |
NCT03568799 -
4-[18F]Fluoroglutamine PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
|
N/A | |
Not yet recruiting |
NCT02817048 -
Tubeless VATS for Peripheral Lung Nodule
|
N/A | |
Recruiting |
NCT01149187 -
Usefulness of Interferon-gamma Release Assay in Diagnosing Pulmonary Nodules
|
N/A | |
Completed |
NCT00925210 -
Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach
|
Phase 2 | |
Completed |
NCT02448225 -
18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules
|
Phase 2 | |
Active, not recruiting |
NCT05171491 -
LungLB in Subjects Presenting With Indeterminate Pulmonary Nodules
|
||
Terminated |
NCT04140474 -
Evaluation of the Archimedes ™ System for Transparenchymatous Access to Pulmonary Nodules.
|
N/A | |
Not yet recruiting |
NCT02653859 -
Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules
|
N/A | |
Completed |
NCT02832284 -
iNod System Human Feasibility Assessment
|
N/A | |
Recruiting |
NCT02773992 -
Clinical Study of Three Plus Two Type Early Diagnosis of Pulmonary Nodules in Medical Internet of Things
|
N/A |